tiprankstipranks
Advertisement
Advertisement

ARCT Stock Latest News

Arcturus Therapeutics initiated with a Buy at B. Riley
The FlyArcturus Therapeutics initiated with a Buy at B. Riley
15d ago
ARCT
Arcturus Therapeutics price target lowered to $21 from $66 at Canaccord
PremiumThe Fly
Arcturus Therapeutics price target lowered to $21 from $66 at Canaccord
28d ago
ARCT
Regulatory Shifts Cloud Arcturus Therapeutics’ Outlook as FDA Delays KOSTAIVE BLA and Demands New COVID-19 Efficacy Data
PremiumCompany Announcements
Regulatory Shifts Cloud Arcturus Therapeutics’ Outlook as FDA Delays KOSTAIVE BLA and Demands New COVID-19 Efficacy Data
28d ago
ARCT
Arcturus Therapeutics Balances Pipeline Progress With Cash Strain
PremiumCompany Announcements
Arcturus Therapeutics Balances Pipeline Progress With Cash Strain
28d ago
ARCT
Arcturus Therapeutics price target lowered to $25 from $72 at Piper Sandler
PremiumThe Fly
Arcturus Therapeutics price target lowered to $25 from $72 at Piper Sandler
29d ago
ARCT
Arcturus Therapeutics: Dose Selection and Trial Design Uncertainty Justify Neutral Rating Despite Modestly Higher Target Price
PremiumRatingsArcturus Therapeutics: Dose Selection and Trial Design Uncertainty Justify Neutral Rating Despite Modestly Higher Target Price
29d ago
ARCT
Validating Arcturus’s mRNA Platform: Early Clinical Proof, Solid Cash, and Asymmetric Upside Support a Buy Rating
Premium
Ratings
Validating Arcturus’s mRNA Platform: Early Clinical Proof, Solid Cash, and Asymmetric Upside Support a Buy Rating
29d ago
ARCT
Arcturus Therapeutics price target raised to $8 from $7 at Citi
Premium
The Fly
Arcturus Therapeutics price target raised to $8 from $7 at Citi
29d ago
ARCT
Arcturus Therapeutics reports Q4 EPS ($1.03), consensus (76c)
PremiumThe Fly
Arcturus Therapeutics reports Q4 EPS ($1.03), consensus (76c)
29d ago
ARCT
Options Volatility and Implied Earnings Moves Today, March 03, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 03, 2026
30d ago
AZO
BBY
ARCT Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ARCT Earnings this Week: How Will it Perform?
1M ago
ARCT
Arcturus’ ARCT-2304 Flu Vaccine Trial Reaches Phase 1 Finish Line: What Investors Should Watch Next
PremiumCompany Announcements
Arcturus’ ARCT-2304 Flu Vaccine Trial Reaches Phase 1 Finish Line: What Investors Should Watch Next
2M ago
ARCT
Arcturus Therapeutics initiated with a Buy at Roth Capital
PremiumThe FlyArcturus Therapeutics initiated with a Buy at Roth Capital
2M ago
ARCT
Arcturus Therapeutics price target lowered to $7 from $9 at Citi
Premium
The Fly
Arcturus Therapeutics price target lowered to $7 from $9 at Citi
3M ago
ARCT
Arcturus Therapeutics files $500M mixed securities shelf
Premium
The Fly
Arcturus Therapeutics files $500M mixed securities shelf
3M ago
ARCT
Arcturus Therapeutics Announces CFO Departure and Replacement
PremiumCompany Announcements
Arcturus Therapeutics Announces CFO Departure and Replacement
4M ago
8K
ARCT
Arcturus Therapeutics price target lowered to $9 from $12 at Citi
PremiumThe Fly
Arcturus Therapeutics price target lowered to $9 from $12 at Citi
5M ago
ARCT
Arcturus Therapeutics: Promising Developments and Strong Financial Position Justify Buy Rating
PremiumRatings
Arcturus Therapeutics: Promising Developments and Strong Financial Position Justify Buy Rating
5M ago
ARCT
Arcturus Therapeutics Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Arcturus Therapeutics Earnings Call: Progress Amid Challenges
5M ago
ARCT
Arcturus Therapeutics price target lowered to $72 from $140 at Piper Sandler
PremiumThe FlyArcturus Therapeutics price target lowered to $72 from $140 at Piper Sandler
5M ago
ARCT
Arcturus Therapeutics Reports Q3 2025 Financials and Pipeline Progress
Premium
Company Announcements
Arcturus Therapeutics Reports Q3 2025 Financials and Pipeline Progress
5M ago
ARCT
Arcturus Therapeutics reports Q3 EPS (49c), consensus (80c)
Premium
The Fly
Arcturus Therapeutics reports Q3 EPS (49c), consensus (80c)
5M ago
ARCT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >